May 29, 2024 · Aspirin, a nonsteroidal anti-inflammatory drug (NSAID), is inversely associated with colorectal cancer (CRC) risk. In meta-analyses and ...
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer. Sci Adv. 2024 May 31;10(22):eadk3121 ...
May 29, 2024 · Aspirin, a nonsteroidal anti-inflammatory drug (NSAID), is inversely associated with colorectal cancer (CRC) risk. In meta-analyses and ...
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer. Science advances. Authors. David Drew.
Dive into the research topics of 'Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer'.
Two genome-wide interaction loci modify the association of ...
ui.adsabs.harvard.edu › abs › abstract
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer ... Abstract. Regular, long-term aspirin ...
May 31, 2024 · Background: Regular use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with lower risk of colorectal cancer (CRC). Genome-wide ...
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer. David A Drew, Andre E Kim, Yi Lin ...
Dive into the research topics of 'Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer'.
May 31, 2024 · Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer. Drew, D. A. ; Kim ...